These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 29945940)
1. The remarkable diversity of thrombotic thrombocytopenic purpura: a perspective. George JN Blood Adv; 2018 Jun; 2(12):1510-1516. PubMed ID: 29945940 [TBL] [Abstract][Full Text] [Related]
2. Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy. Joly BS; Stepanian A; Leblanc T; Hajage D; Chambost H; Harambat J; Fouyssac F; Guigonis V; Leverger G; Ulinski T; Kwon T; Loirat C; Coppo P; Veyradier A; Lancet Haematol; 2016 Nov; 3(11):e537-e546. PubMed ID: 27720178 [TBL] [Abstract][Full Text] [Related]
3. Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency. George JN; Chen Q; Deford CC; Al-Nouri Z J Clin Apher; 2012; 27(6):302-11. PubMed ID: 22927184 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in thrombotic thrombocytopenic purpura. Sadler JE; Moake JL; Miyata T; George JN Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695 [TBL] [Abstract][Full Text] [Related]
5. Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state. Browning S; Bahar B; Lee AI; Gorshein E Hematology; 2020 Dec; 25(1):473-477. PubMed ID: 33269995 [TBL] [Abstract][Full Text] [Related]
6. The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: evaluation, management, and long-term outcomes experience of the Oklahoma TTP-HUS Registry, 1989-2007. George JN Kidney Int Suppl; 2009 Feb; (112):S52-4. PubMed ID: 19180137 [TBL] [Abstract][Full Text] [Related]
7. Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Reese JA; Muthurajah DS; Kremer Hovinga JA; Vesely SK; Terrell DR; George JN Pediatr Blood Cancer; 2013 Oct; 60(10):1676-82. PubMed ID: 23729372 [TBL] [Abstract][Full Text] [Related]
8. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic and therapeutic challenges in the thrombotic thrombocytopenic purpura and hemolytic uremic syndromes. George JN; Al-Nouri ZL Hematology Am Soc Hematol Educ Program; 2012; 2012():604-9. PubMed ID: 23233641 [TBL] [Abstract][Full Text] [Related]
10. Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature. Elliott MA; Heit JA; Pruthi RK; Gastineau DA; Winters JL; Hook CC Eur J Haematol; 2009 Oct; 83(4):365-72. PubMed ID: 19508684 [TBL] [Abstract][Full Text] [Related]
11. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays. McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997 [TBL] [Abstract][Full Text] [Related]